Towards understanding brain-gut-microbiome connections in Alzheimer’s disease

BackgroundAlzheimer’s disease (AD) is complex, with genetic, epigenetic, and environmental factors contributing to disease susceptibility and progression. While significant progress has been made in understanding genetic, molecular, behavioral, and neurological aspects of AD, relatively little is known about which environmental factors are important in AD etiology and how they interact with genetic factors in the development of AD. Here, we propose a data-driven, hypotheses-free computational approach to characterize which and how human gut microbial metabolites, an important modifiable environmental factor, may contribute to various aspects of AD.Materials and methodsWe integrated vast amounts of complex and heterogeneous biomedical data, including disease genetics, chemical genetics, human microbial metabolites, protein-protein interactions, and genetic pathways. We developed a novel network-based approach to model the genetic interactions between all human microbial metabolites and genetic diseases. We identified metabolites that share significant genetic commonality with AD in humans. We developed signal prioritization algorithms to identify the co-regulated genetic pathways underlying the identified AD-metabolite (brain-gut) connections.ResultsWe validated our algorithms using known microbial metabolite-AD associations, namely AD-3,4-dihydroxybenzeneacetic acid, AD-mannitol, and AD-succinic acid. Our study provides supporting evidence that human gut microbial metabolites may be an important mechanistic link between environmental exposure and various aspects of AD. We identified metabolites that are significantly associated with various aspects in AD, including AD susceptibility, cognitive decline, biomarkers, age of onset, and the onset of AD. We identified common genetic pathways underlying AD biomarkers and its top one ranked metabolite trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. These coregulated pathways between TMAO-AD may provide insights into the mechanisms of how dietary meat and fat contribute to AD.ConclusionsEmploying an integrated computational approach, we provide intriguing and supporting evidence for a role of microbial metabolites, an important modifiable environmental factor, in AD etiology. Our study provides the foundations for subsequent hypothesis-driven biological and clinical studies of brain-gut-environment interactions in AD.

[1]  J. Manson,et al.  Dietary fat types and 4‐year cognitive change in community‐dwelling older women , 2012, Annals of neurology.

[2]  R S Wilson,et al.  Dietary fat intake and 6-year cognitive change in an older biracial community population , 2004, Neurology.

[3]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[4]  R. Xu,et al.  Network-based gene prediction for Plasmodium falciparum malaria towards genetics-based drug discovery , 2015, BMC Genomics.

[5]  D Kromhout,et al.  Dietary intake of fatty acids and fish in relation to cognitive performance at middle age , 2004, Neurology.

[6]  Walter Sanseverino,et al.  Use of targeted SNP selection for an improved anchoring of the melon (Cucumis melo L.) scaffold genome assembly , 2015, BMC Genomics.

[7]  Rong Xu,et al.  PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discovery , 2015, J. Biomed. Informatics.

[8]  Wenhua Liu,et al.  Parkin Suppresses the Expression of Monoamine Oxidases* , 2006, Journal of Biological Chemistry.

[9]  M. Paik,et al.  Urinary polyamines and N-acetylated polyamines in four patients with Alzheimer's disease as their N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry in selected ion monitoring mode. , 2006, Analytica chimica acta.

[10]  Alexander A. Morgan,et al.  Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.

[11]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[12]  D. Butterfield,et al.  Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. , 2007, Frontiers in bioscience : a journal and virtual library.

[13]  Alexander A. Morgan,et al.  Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.

[14]  Li Li,et al.  Phenome-driven disease genetics prediction toward drug discovery , 2015, Bioinform..

[15]  Yang Chen,et al.  Combing Human Disease Genetics and Mouse Model Phenotypes Towards Drug Repositioning for Parkinson's Disease , 2015, AMIA.

[16]  Brian J. Bennett,et al.  Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. , 2013, Cell metabolism.

[17]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[18]  L. Thal,et al.  Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. , 2002, Free radical biology & medicine.

[19]  C. Rice-Evans,et al.  Bioavailability of ferulic acid. , 1998, Biochemical and biophysical research communications.

[20]  Hubert Blain,et al.  Abnormal Substrate Levels That Depend upon Mitochondrial Function in Cerebrospinal Fluid from Alzheimer Patients , 1998, Gerontology.

[21]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[22]  Li Li,et al.  A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat , 2015, BMC Genomics.

[23]  Donald Silberberg,et al.  National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease* and Cognitive Decline , 2010, Annals of Internal Medicine.

[24]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[25]  M. Rossor,et al.  Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component , 2009, Proceedings of the National Academy of Sciences.

[26]  Y. Moreau,et al.  Computational tools for prioritizing candidate genes: boosting disease gene discovery , 2012, Nature Reviews Genetics.

[27]  Damian Szklarczyk,et al.  STITCH 4: integration of protein–chemical interactions with user data , 2013, Nucleic Acids Res..

[28]  C. Bell,et al.  NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. , 2010, NIH consensus and state-of-the-science statements.

[29]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[30]  Xiaoshu Cai,et al.  Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease. , 2015, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[31]  C. Parsons,et al.  Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections , 2012, British journal of pharmacology.

[32]  H. Tanila,et al.  Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting β-Amyloid Burden , 2007, The Journal of Neuroscience.

[33]  Mikael Fogelholm,et al.  Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013 .

[34]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.

[35]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[36]  L. Lerman,et al.  The Mediterranean diet, its components, and cardiovascular disease. , 2015, The American journal of medicine.

[37]  Zeneng Wang,et al.  Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk , 2013 .

[38]  M. Schapiro,et al.  Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. , 1996, Clinical chemistry.

[39]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[40]  E. Graf,et al.  Antioxidant potential of ferulic acid. , 1992, Free radical biology & medicine.

[41]  T. Dinan,et al.  Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .

[42]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[43]  C. Steer,et al.  Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. , 2008, Trends in molecular medicine.

[44]  D. Goldstein,et al.  Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer’s disease , 1999, Biological Psychiatry.

[45]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[46]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[47]  H. Ling,et al.  Genome-wide identification and characterization of the bHLH gene family in tomato , 2015, BMC Genomics.

[48]  Rong Xu,et al.  DenguePredict: An Integrated Drug Repositioning Approach towards Drug Discovery for Dengue , 2015, AMIA.